Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

BACKGROUND: A safe and effective vaccine for the prevention of human immunodeficiency virus type 1 (HIV-1) infection is a global priority. We tested the efficacy of a DNA prime–recombinant adenovirus type 5 boost (DNA/rAd5) vaccine regimen in persons at increased risk for HIV-1 infection in the Unit...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Hammer, Scott M., Sobieszczyk, Magdalena E., Janes, Holly, Karuna, Shelly T., Mulligan, Mark J., Grove, Doug, Koblin, Beryl A., Buchbinder, Susan P., Keefer, Michael C., Tomaras, Georgia D., Frahm, Nicole, Hural, John, Anude, Chuka, Graham, Barney S., Enama, Mary E., Adams, Elizabeth, DeJesus, Edwin, Novak, Richard M., Frank, Ian, Bentley, Carter, Ramirez, Shelly, Fu, Rong, Koup, Richard A., Mascola, John R., Nabel, Gary J., Montefiori, David C., Kublin, James, McElrath, M. Juliana, Corey, Lawrence, Gilbert, Peter B.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2013
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4030634/
https://ncbi.nlm.nih.gov/pubmed/24099601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1310566
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia